- Home
- IMMX vs GROV Comparison
IMMX vs GROV Comparison
Compare IMMX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- GROV
- Stock Information
- Founded
- IMMX 2014
- GROV 2016
- Country
- IMMX United States
- GROV United States
- Employees
- IMMX N/A
- GROV N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- GROV Package Goods/Cosmetics
- Sector
- IMMX Health Care
- GROV Consumer Discretionary
- Exchange
- IMMX Nasdaq
- GROV Nasdaq
- Market Cap
- IMMX 54.9M
- GROV 57.6M
- IPO Year
- IMMX 2021
- GROV N/A
- Fundamental
- Price
- IMMX $2.04
- GROV $1.39
- Analyst Decision
- IMMX Strong Buy
- GROV Hold
- Analyst Count
- IMMX 1
- GROV 1
- Target Price
- IMMX $7.00
- GROV $1.20
- AVG Volume (30 Days)
- IMMX 398.8K
- GROV 113.2K
- Earning Date
- IMMX 06-10-2025
- GROV 05-14-2025
- Dividend Yield
- IMMX N/A
- GROV N/A
- EPS Growth
- IMMX N/A
- GROV N/A
- EPS
- IMMX N/A
- GROV N/A
- Revenue
- IMMX N/A
- GROV $193,427,000.00
- Revenue This Year
- IMMX N/A
- GROV N/A
- Revenue Next Year
- IMMX N/A
- GROV $6.19
- P/E Ratio
- IMMX N/A
- GROV N/A
- Revenue Growth
- IMMX N/A
- GROV N/A
- 52 Week Low
- IMMX $1.26
- GROV $1.02
- 52 Week High
- IMMX $3.00
- GROV $1.95
- Technical
- Relative Strength Index (RSI)
- IMMX 65.54
- GROV 59.55
- Support Level
- IMMX $1.89
- GROV $1.30
- Resistance Level
- IMMX $2.50
- GROV $1.41
- Average True Range (ATR)
- IMMX 0.18
- GROV 0.10
- MACD
- IMMX 0.04
- GROV 0.02
- Stochastic Oscillator
- IMMX 85.71
- GROV 77.72
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.